Archives
March 25, 2019 About 19,000 Australians have taken advantage of anti-HIV drugs in the first two years of groundbreaking PrEP regimen being subsidised via the Pharmaceutical Benefits Scheme. Researchers point to the increasing number of HIV-positive Australians starting early antiretroviral treatment to prevent its development and spread. The latest surveillance ... Read More